Lazard Healthcare Services Leaders Study 2024

The Lazard Healthcare Services Leaders Study 2024 presents findings from a survey conducted among 183 leaders in the healthcare services sector, including corporate executives and investors. The study reflects on the previous year's predictions and assesses the current state of the market, highlighting ongoing challenges such as elevated inflation and interest rates that have impacted transaction activity and valuations. The report indicates that a significant portion of respondents do not anticipate a recovery conducive to IPOs until at least the second half of 2024 or 2025. It also notes that healthcare IT, mental health, and home health are expected to attract more investment in 2024. The study emphasizes the potential impact of macroeconomic factors and investor sentiment on market recovery, while also addressing the anticipated effects of political outcomes on the healthcare landscape. Overall, the findings underscore the cautious optimism among industry leaders regarding future market conditions.